Product Information
BUPROPION HCL XL 150 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0779 per EA under NDC 16571086203. Its NADAC has been published 192 times since Oct 26, 2022.
Strength
150 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571086203
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
BUPROPION HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA211020On Market Since
8/1/2022
Pharmacological Classes
Price Statistics
The NADAC for BUPROPION HCL XL 150 MG TABLET has been published 192 times since Oct 26, 2022, and over the history we have for it it has declined 29.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0779 per EA |
|---|---|
| All-time high | $0.1215 (Apr 10, 2024) |
| All-time low | $0.0745 (Nov 20, 2024) |
| 52-week high | $0.1042 |
| 52-week low | $0.0770 |
| Median price | $0.1015 |
| Average price | $0.1001 |
| Largest weekly change | -30.3% (Nov 20, 2024) |
| Weeks tracked | 192 |
| Tracking since | Oct 26, 2022 |
Generic Alternatives
The matcher finds 14 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BUPROPION HCL XL 150 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUPROPION HCL XL 150 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.0779 per EA (NDC 16571086203), effective Jun 24, 2026.
How has the price of BUPROPION HCL XL 150 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUPROPION HCL XL 150 MG TABLET has declined 29.6%. It has been tracked across 192 weekly CMS publications since Oct 26, 2022.
What are the highest and lowest recorded NADAC prices for BUPROPION HCL XL 150 MG TABLET?
Since Oct 26, 2022, the NADAC for BUPROPION HCL XL 150 MG TABLET has ranged from a low of $0.0745 (Nov 20, 2024) to a high of $0.1215 (Apr 10, 2024), with a median of $0.1015 per EA.
Are there cheaper alternatives to BUPROPION HCL XL 150 MG TABLET?
14 NADAC-published products share the same active ingredient, strength, and dosage form as BUPROPION HCL XL 150 MG TABLET, but none are currently priced below it.
Who manufactures BUPROPION HCL XL 150 MG TABLET?
BUPROPION HCL XL 150 MG TABLET (NDC 16571086203) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification